Rate Video

VJVirtual | Clinicopathologic models in prostate cancer: impact of a 22-gene genomic classifier

Eric Klein • 3 Apr 2020

Genitourinary Cancer Prostate Cancer

Eric Klein, MD, Glickman Urology & Kidney Institute, Cleveland, OH, discusses a publication he co-authored on genomic classifiers in prostate cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Genomic testing: a precision-medicine approach applied to early-stage prostate cancer

Eric Klein • 5 Jun 2016

Role of genomic profiling in the management of intermediate-risk prostate cancer

Eric Klein • 18 Oct 2022

Polygenic risk scores for the early detection of prostate cancer

Eric Klein • 18 Oct 2022

Sensitive and specific multi-cancer detection

Eric Klein • 6 Apr 2020

Related Videos

Challenges of nmCRPC management: to treat or not?

Improving the current chemotherapy standard: a role for DNA methyltransferase inhibitors

Cabozantinib plus docetaxel and prednisone in mCRPC

Munjid Al Harthy

How to involve patients in clinical decision making